CDH2 and urogenital neoplasm: During prostate carcinogenesis, EMT is related to cancer progression, migration and metastasis, and mesenchymal markers and transcription factors, such as vimentin, N-cadherin, Snai1, and Twist1/2, are highly upregulated [58].